Pfizer
PFE
3,266 hedge funds and large institutions have $202B invested in Pfizer in 2022 Q4 according to their latest regulatory filings, with 342 funds opening new positions, 1,269 increasing their positions, 1,340 reducing their positions, and 102 closing their positions.
235% more first-time investments, than exits
New positions opened: 342 | Existing positions closed: 102
24% more funds holding in top 10
Funds holding in top 10: 156 → 193 (+37)
20% more capital invested
Capital invested by funds: $169B → $202B (+$33.1B)
12% more call options, than puts
Call options by funds: $3.09B | Put options by funds: $2.77B
6% more funds holding
Funds holding: 3,086 → 3,266 (+180)
0.47% more ownership
Funds ownership: 69.23% → 69.7% (+0.47%)
5% less repeat investments, than reductions
Existing positions increased: 1,269 | Existing positions reduced: 1,340
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$492M |
| 2 |
JP Morgan Chase
New York
|
+$462M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$386M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$381M |
| 5 |
Morgan Stanley
New York
|
+$356M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$553M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$442M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$418M |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$189M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$181M |
PFE Hedge Fund Activity: Q4 2022 in Review
3,266 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2022, worth a combined $202B — up 20% from $169B a quarter earlier.
Buyers outnumbered sellers: 342 funds opened new PFE positions and 102 closed out — a net gain of 240 holders — while 1,269 added to existing stakes and 1,340 trimmed.
The largest buyer was BlackRock, adding an estimated $492M. The largest seller was Wellington Management Group, cutting an estimated $553M.
- 3,266 institutional investors held Pfizer (PFE) as of Q4 2022, up from 3,086 in Q3 2022.
- Funds reported $202B of Pfizer stock for Q4 2022, up 20% quarter-over-quarter.
- 342 funds opened new Pfizer positions in Q4 2022 and 102 closed out, a net change of +240 holders.
- The largest Pfizer buyer in Q4 2022 was BlackRock, an estimated $492M added.
- The largest Pfizer seller in Q4 2022 was Wellington Management Group, an estimated $553M sold.
Based on aggregated 13F filings for Q4 2022.